KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease?mineral and bone disorder (CKD?MBD)
Disorders in mineral metabolism and bone disease are common complications of chronic kidney disease (CKD), and a significant cause of the morbidity and decreased quality of life of CKD patients. Importantly, there is an increasing body of convincing evidence suggesting that these disorders are associated with the increased risk for cardiovascular calcification, morbidity and mortality of these patients. The absence of a precise terminology and uniform classification of these abnormalities has hampered communication and comparison of reported research results, as well as the management of CKD patients afflicted by these disorders. In December of 2004, the Board of Directors of Kidney Disease: Improving Global Outcomes (KDIGO) selected addressing this gap as a priority action item.
|Authors||Kidney Disease: Improving Global Outcomes (KDIGO) CKD?MBD Work Group|
|Responsible Garvan Author|
|Publisher Name||KIDNEY INTERNATIONAL|
|Published Pages||(Suppl 13)|
|URL link to publisher's version||http://www.kdigo.org/clinical_practice_guidelines_1.php|
|OpenAccess link to author's accepted manuscript version||https://publications.gimr.garvan.org.au/open-access/10334|